Beyond Standardized Therapies in Rheumatoid Arthritis Emerging Options and Patient Management Strategies Once you have submitted your answers to the questions below, you will move to the CME Evaluation and Request for Credit Form, where you will also be able to read the monograph and/or to download it for later reading. You must complete the CME Evaluation and Request for Credit Form to receive CME credit for participating in this activity. Should you choose to return to this activity at a later time, you will be automatically directed to the CME Evaluation and Request for Credit Form. Please Indicate Your Profession. Rheumatologist Primary care physician Physician assistant/Nurse practitioner Physical therapist Other Which Best Describes Your Work Environment?Academic Staff-model health maintenance organization Single-specialty practice Multispecialty practice Fellowship/training Other     How Many Years Have You Been in Practice?1-5 years 6-10 years 11-15 years 16-20 years 21+ years N/A How Many Patients With Rheumatoid Arthritis Do You See per Week?1-5 6-10 11-15 16-20 21+ N/A     All DMARDS produce both clinical and radiographic remission in patients with RA. Strongly Disagree Disagree Somewhat Disagree Somewhat Agree Agree Strongly Agree Biologics other than anti-TNF agents are more efficacious for the treatment of RA as first-line therapy compared with second- and third-line. Strongly Disagree Disagree Somewhat Disagree Somewhat Agree Agree Strongly Agree     B-cell—targeted therapy has not shown both clinical and radiographic efficacy when used in patients with active RA. Strongly Disagree Disagree Somewhat Disagree Somewhat Agree Agree Strongly Agree Antibodies to IL-6 show promise for the treatment of RA. Strongly Disagree Disagree Somewhat Disagree Somewhat Agree Agree Strongly Agree